Dr. Schapira puts the ASCO Annual Meeting in context for people with cancer and their families.
From June 3 to June 7, oncology professionals from around the world will meet to discuss the latest in cancer research. If you can’t wait to learn about the latest research, check here for early highlights released in advance of the 2016 ASCO Annual Meeting.
As the ASCO Annual Meeting approaches, Dr. Schapira discusses the benefits and risks of clinical trials and the role patients can have in the future of cancer research.
Research presented this weekend at the 2016 Cancer Survivorship Symposium will address some of the challenges patients face after treatment ends.
Two sisters and breast cancer advocates share what they learned at the 2015 Palliative Care in Oncology Symposium.
Research presented this weekend will highlight the importance of integrating oncology and palliative care.
Patient advocate Diana Chingos wanted to attend the 2015 ASCO Annual Meeting to learn about the latest cancer research. After four intense days of posters and presentations, she left Chicago with a mountain of new knowledge and four key insights.
Two out of three people now live at least five years after being diagnosed with cancer, but there is still more to be done. Researchers at the 2015 ASCO Annual Meeting showed how new treatment options can continue to improve and lengthen the lives of people with both rare and common cancers.
This year, President Obama has focused attention on treatments and tools that help doctors tailor medical care for individual patients. Research presented at the 2015 ASCO Annual Meeting shows how targeted therapies can be used to improve the care of people with a number of different types of blood cancer.
Immunotherapy is one of the hottest topics in cancer research. This year, focus at the ASCO Annual Meeting has been on a type of immunotherapy called PD-1 inhibitors. Learn how these drugs may help improve the treatment of head and neck, liver, and lung cancers.